Co-Diagnostics Inc. (CODX)
CODX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.06
-14.80% on the day
Market cap
$7.5M
Nano cap
Revenue · 2025
$622K
-84.1% on 2024
Net income · 2025
-$47.0M
-7550.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CODX on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0001692415 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | UT |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $622K |
| Net income | -$47.0M |
| Operating income | -$50.2M |
| Net margin | -7550.3% |
| Operating margin | -8058.8% |
| Revenue growth | -84.1% |
| Cash | $11.9M |
| Total assets | $24.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 12.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-24 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-13 |
| Latest proxy | PRE 14A | 2026-09-21 |
Source: SEC EDGAR submissions feed, 385 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AEMD | Aethlon Medical Inc. | $5.58 | -4.78% | $9.0M |
| WOK | WORK Medical Technology Group LTD | $1.39 | -3.47% | $6.2M |
| AMIX | Autonomix Medical Inc. | $3.01 | -2.90% | $5.9M |
| SNOA | Sonoma Pharmaceuticals Inc. | $1.18 | -4.07% | $5.7M |
| NMTC | NeuroOne Medical Technologies Corporation | $1.10 | +2.33% | $10.0M |
| NVNO | enVVeno Medical Corporation | $7.97 | -2.21% | $5.5M |
| CTSO | Cytosorbents Corporation | $3.46 | -3.62% | $10.9M |
| INBS | Intelligent Bio Solutions Inc. | $1.48 | -1.99% | $4.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier